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Identity 
Other names: MIRN449, MIRN449A, hsa-mir-449 




The microRNA-449 family is a group of three small, 
non-coding RNAs first identified in embryonic mice 
(Mineno et al., 2006; Wheeler et al., 2006) and highly 
conserved in different species.  
The whole cluster consists of three members in human: 
miR-449a (MI0001648), miR-449b (MI0003673), and 
miR-449c (MI0003823), they are located in the second 
intron of the Cdc20b gene and they share its promoter. 
Sequence miR-449a: uggcaguguauuguuagcuggu (22 
bp) 
Sequence miR-449b: aggcaguguauuguuagcuggc (22 
bp) 
Sequence miR-449c: uaggcaguguauugcuagcggcugu (25 
bp) 
They regulate gene expression post-transcriptionally by 
mRNA degradation or translational repression 
(Esquela-Kerscher and Slack, 2006). 
 
 
A) Alignment of the mature sequences of the miR-34/449 family members. Modified from Lizé et al., 2010.  
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B) Genomic localization of miR-449 family on chromosome 5q11.2 (source: www.ncbi.nlm.nih.gov/gene/). 
 
Transcription 
Transcription starts from chromosome 5: 54466360-
54466450 [-] in human. E2F1 is a transcriptional 
activator of the locus (Yang et al., 2009; Lizé et al.,
2010), IL-13 a repressor (Solberg et al., 2012). 
The synthesis of miRNAs starts with the primary 
transcription by the RNA polymerase II (Lee et al., 
2004) in the nucleus of a capped and polyadenylated 
precursor named pri-miRNA.  
The pri-miRNA of miR-449a is 91 base pairs long, the
one of miR-449b is 97 bp in and pri-miR-449c is 92 bp 
in.  
The precursors are then further processed by the 
nucleases Drosha and Pasha, which are able to 
recognize and cut the stem-loop structure to generate 
the pre-miRNA.  
Finally, these pre-miRNAs are exported into the 
cytoplasm and are cleaved by the ribonuclease Dicer 
(Lund and Dahlberg, 2006) to get the mature 22-25 bp 
miR-449.  
The mature microRNA recognizes its target mostly via 
the "seed sequence", and when loaded into the RNA 
induced silencing complex (RISC), they lead to the 
degradation or the inhibition of the translation of the 
targeted mRNA (Hammond et al., 2000). 
Expression 
miR-449 expression is strongly induced during 
mucociliary differentiation (Lizé et al., 2010; Marcet et 
al., 2011).  
miR-449 is down-regulated in various cancers, most 
probably through epigenetic silencing (Yang et al., 
2009; Noonan et al., 2009; Lizé et al., 2010; Noonan et 
al., 2010; Bou Kheir et al., 2011; Buurman et al., 2012; 
Chen et al., 2012).  
miR-449 is E2F1- and DNA damage responsive and 
negatively regulates the E2F pathway both through the 
direct targeting of E2F transcription factors and 
indirectly through the downregulation of cyclin-
dependent kinases (CDKs) either directly or through 
the induction of the CDK-inhibitor p21 (Yang et al., 
2009; Lizé et al., 2010). miR-449's promoter is 
repressed by Interleukin 13 (IL-13), leading to an 
increase in Notch expression and mucociliary 
differentiation alteration (Solberg et al., 2012). MiR-
449 targets: cyclin dependent kinase 6 (CDK6), cell
division cycle 25 homolog A (CDC25A); and histone 
deacetylase 1 (HDAC1), cyclin D1 (CCND1), cyclin 
E2 (CCNE2), SIRT1, Delta-like 1 (DLL1), E2F 
transcription factor 5 (E2F5), Geminin (GMNN), MET 
protooncogene (MET), v-myc avian myelocytomatosis 
viral related oncogene, neuroblastoma derived (N-
myc), Drosophila notch homolog 1 (Notch1) (Bommer 
et al., 2007; Sun et al., 2008; Noonan et al., 2009; 
Redshaw et al., 2009; Yang et al., 2009; Lizé et al., 
2010; Bou Kheir et al., 2011; Buechner et al., 2011; 
Lizé et al., 2011; Marcet et al., 2011). 
Localisation 
miR-449 is expressed at high levels in tissues 
containing ciliated cells, especially choroid plexus 
(Redshaw et al., 2009), lung, testis and trachea (Lizé et 
al., 2010; Marcet et al., 2011; Bao et al., 2012).  
It is expressed specifically in multiciliated cells 
(Marcet et al., 2011). 
Function 
miR-449 is a strong inducer of cell cycle arrest 
(including senescence) and apoptosis in tumor cell lin s 
(Noonan et al., 2009; Yang et al., 2009; Lizé et al.,
2010; Noonan et al., 2010; Bou Kheir et al., 2011). It is 
also involved in mucociliary differentiation (Lizé et al., 
2010; Marcet et al., 2011). 
miR-449 regulates several pathways (reviewed in Lizé 
et al., 2011) including Notch (Capuano et al., 2011; 
Marcet et al., 2011), p53 (Lizé et al., 2010), E2F-Rb 
(Redshaw et al., 2009; Yang et al., 2009; Lizé et al., 
2010; Noonan et al., 2010; Bao et al., 2012), Wnt 
(Iliopoulos et al., 2009) and the cell cycle (Noonan et 
al., 2009; Yang et al., 2009; Lizé et al., 2010; Noonan 
et al., 2010; Bou Kheir et al., 2011). 
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A) Stem-loop structure of miR-449a. B) Stem-loop structure of miR-449b. C) Stem-loop structure of miR-449c. The sequence of the 




MicroRNAs are not translated into proteins. See DNA 
for further description. 
Mutations 
Note 




MiR-449 functions as a tumor suppressor and is down-
regulated in various cancer cells (Yang et al., 2009; 
Lizé et al., 2010; Ma and Tao, 2012) such as: lung 
adenocarcinoma and squamous cell carcinoma (Liang 
2008), prostate cancer (Noonan et al., 2009), 
craniopharyngioma (Campanini et al., 2010), colon 
cancer cells (Wang et al., 2010), gastric cancer (Bou 
Kheir et al., 2011), hepatocellular carcinoma (Buurman 
et al., 2012), bladder cancer (Chen et al., 2012); while 
it is up-regulated in endometrioid adenocarcinoma (Wu 
et al., 2009). 
Lung cancer 
Note 
In silico studies reveal that miR-449 may be down-
regulated in different kinds of lung cancer such as lung 
adenocarcinoma and squamous cell carcinoma (Liang, 
2008).  
miR-449 is strongly down-regulated in the lung 
carcinoma cell line H1299 in comparison to normal 
lung tissue (Lizé et al., 2010). 
Prostate cancer 
Note 
In prostate cancer, miR-449 has a role in cell growth 
regulation by repressing the histone deacetylase 1 
(HDAC-1) expression. The activation of HDAC1 by 
the loss of miR-449 in prostate cancer cells is critical 
for their epigenetic evolution (Noonan et al., 2009). 
Craniopharyngioma 
Note 
The down-regulation of miR-449 may have a role in 
the inhibition of the Wnt signaling pathway in 
craniopharyngioma (Campanini et al., 2010). 
Gastric cancer 
Note 
miR-449 is down-regulated or even absent in mouse 
models of gastric cancer and in primary human gastric 
tumors (Wang et al., 2010; Bou Kheir et al., 2011). 
Although the development of gastric cancer is 
primarily related to H. Pylori infection, levels ofgastrin 
are also involved in gastric cancer. Studies of the miR-
449b expression in Gastrin knockout mice and in mice 
infected by H. pylori showed that, in both cases, the
miR-449b is down-regulated compared to the control 
mice. Moreover, ectopic expression of miR-449b in 
SNU638 cells affects their proliferation and leads to 
apoptosis and senescence. 
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Hepatocellular carcinoma 
Note 
MiR-449 is down-regulated in hepatocellular 
carcinoma which results in high levels of histone 
deacetylases, leading to increased c-MET. C-Met is the 
receptor for hepatocyte growth factor in hepatocellular 
carcinoma cells (Buurman et al., 2012). 
Bladder cancer 
Note 
miR-449a is downregulated in bladder cancer cells as 
compared to normal tissue. Reintroduction of miR-449 
in the bladder cancer cell lines T24 and 5537 lead 
rather to cell cycle arrest than to apoptosis. The 
inhibition of the tumor growth by using liposome 




MiR-449 is up-regulated in endometrioid 
adenocarcinoma cells. The expression of the estrogen 
receptor gene, entailed in this cancer type, could be 
regulated by miR-449 (Wu et al., 2009). 
Asthma 
Note 
A common feature of asthma is the alteration of the 
airway epithelial cells. The analyses of asthmatic 
bronchial epithelium showed that interleukin 13 (IL-13) 
contributes to miR-449 repression in asthma. This leads 
to an increase of the Notch expression, which results in 
the reduction of ciliated cell and increase of mucous 
cells (Solberg et al., 2012). 
Primary pigmented nodular 
adrenocortical disease 
Note 
miR-449 is up-regulated in primary pigmented nodular 
adrenocortical disease (PPNAD) (Iliopoulos et al., 
2009). 
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